Gene · 7436
Papers2,532
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,532
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases. | Int J Mol Sci | 2022 | 36077289 | PubTator, text mining | PubMed |
| Clinical, radiological, and genetic variation in pontocerebellar hypoplasia disorder and our clinical experience. | Ital J Pediatr | 2022 | 36076253 | PubTator, text mining | PubMed |
| Lipophorin receptors regulate mushroom body development and complex behaviors in Drosophila. | BMC Biol | 2022 | 36071487 | PubTator, text mining | PubMed |
| LDLR, LRP1, and Megalin redundantly participate in the uptake of Clostridium novyi alpha-toxin. | Commun Biol | 2022 | 36064583 | PubTator, text mining | PubMed |
| 14-weeks combined exercise epigenetically modulated 118 genes of menopausal women with prediabetes. | Front Endocrinol (Lausanne) | 2022 | 36046788 | PubTator, text mining | PubMed |
| Relationship between RELN signaling pathway genes and language development of autism based on a cluster model. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 | 36039581 | PubTator, text mining | PubMed |
| Alternating exosomes and their mimetics as an emergent strategy for targeted cancer therapy. | Front Mol Biosci | 2022 | 36032679 | PubTator, text mining | PubMed |
| Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors. | Drug Deliv | 2022 | 36029014 | PubTator, text mining | PubMed |
| Chemistry, Biosynthesis and Pharmacology of Viniferin: Potential Resveratrol-Derived Molecules for New Drug Discovery, Development and Therapy. | Molecules | 2022 | 36014304 | PubTator, text mining | PubMed |
| HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis. | Int J Mol Sci | 2022 | 36012637 | PubTator, text mining | PubMed |
| Low-Density Lipoprotein Receptor-Related Protein 8 at the Crossroad between Cancer and Neurodegeneration. | Int J Mol Sci | 2022 | 36012187 | PubTator, text mining | PubMed |
| Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism. | Cancers (Basel) | 2022 | 36010867 | PubTator, text mining | PubMed |
| Potential ferroptosis key genes in calcific aortic valve disease. | Front Cardiovasc Med | 2022 | 36003913 | PubTator, text mining | PubMed |
| MicroRNA-199a-3p regulates proliferation and milk fat synthesis of ovine mammary epithelial cells by targeting VLDLR. | Front Vet Sci | 2022 | 35990270 | PubTator, text mining | PubMed |
| Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis. | Neurobiol Aging | 2022 | 35977442 | PubTator, text mining | PubMed |
| Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer. | Aging (Albany NY) | 2022 | 35963622 | PubTator, text mining | PubMed |
| Preliminary genome wide screening identifies new variants associated with coronary artery disease in Indian population. | Am J Transl Res | 2022 | 35958505 | PubTator, text mining | PubMed |
| Comparative transcriptional analysis of satellite glial cell injury response. | Wellcome Open Res | 2022 | 35950162 | PubTator, text mining | PubMed |
| Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma. | Mol Ther Oncolytics | 2022 | 35949950 | PubTator, text mining | PubMed |
| Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1. | Proc Natl Acad Sci U S A | 2022 | 35939689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7436/papers?page=18